Progression of HIV-associated dementia treated with HAART

AIDS Reader

Volumn 12, Issue 2, 2002, Pages 69-74

  Dougherty, Ryan H ^a   Skolasky Jr , Richard L ^a   McArthur, Justin C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CNS; Dementia; HAART; HIV AIDS

Indexed keywords

ABACAVIR; ANTIVIRUS AGENT; INDINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; AGE; ARTICLE; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRUG ABUSE; ETHNOLOGY; FEMALE; FOLLOW UP; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RATING SCALE; TREATMENT OUTCOME;

ADULT; AIDS DEMENTIA COMPLEX; ALGORITHMS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0036196858     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Natural history of HIV infection in the era of combination antiretroviral therapy
2. Epidemiology of human immunodeficiency virus encephalopathy in the United States
3. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
4. HIV-associated neurologic disease incidence changes: Multi-center AIDS Cohort Study, 1990-1998
5. Dementia in AIDS patients: Incidence and risk factors
6. Human immunodeficiency virus-associated dementia
7. The neurobiology of human immunodeficiency virus infections
8. The SIV/macaque model: Unraveling the mysteries of HIV encephalitis
9. Immunocytochemical quantitation of HIV in the brain: Correlation with HIV-associated dementia
10. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists
11. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
12. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
13. Synergistic effects of HIV coat protein and NMDA-receptor mediated neurotoxicity
14. Presentation and course of AIDS dementia complex: Ten years of follow-up in Amsterdam, the Netherlands
15. Variable progression of HIV-associated dementia
16. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex
17. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex
18. Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial
19. Combination antiretroviral therapy including protease inhibitors improves HIV-associated cognitive impairment
20. Safety and efficacy of abacavir (ABC, 1592) in AIDS dementia complex (Study CNAB 3001)
21. Central nervous system (CNS) as a sanctuary of HIV-1 in a patient treated with AZT+3TC+indinavir
22. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (H1V-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force
23. The AIDS dementia complex
24. The HIV dementia scale: A rapid screening test
25. Antiretroviral drugs and the central nervous system
26. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing